Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy

Journal of Veterinary Internal Medicine

Volumn 23, Issue 4, 2009, Pages 840-843

  Meurs, K M ^a   Norgard, M M ^a   Kuan, M ^a   Haggstrom, J ^b   Kittleson, M ^c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular; Genetics; Molecular biology; Nucleic acid sequencing

Indexed keywords

CARRIER PROTEIN; MUSCLE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HYPERTROPHIC CARDIOMYOPATHY; MALE; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CAT DISEASES; CATS; FEMALE; GENE EXPRESSION REGULATION; MALE; MUSCLE PROTEINS; MUTATION;

ANIMALIA; FELIDAE;

EID: 67749111415     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0341.x     Document Type: Article

References (12)

1. Kittleson MD. Feline myocardial disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: Elsevier Saunders; 2000:1082-1103.
2. Meurs KM, Sanchez X, David RM, et al. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Gen 2005; 14: 3587-3593.
3. Meurs KM, Norgard MM, Ederer MM, et al. A substitution mutation in the myosin binding protein C in Ragdoll cats. Genomics 2007; 90: 261-264.
4. Fries R, Heaney AM, Meurs KM. Prevalence of the myosin binding protein C mutation in Maine Coon cats. J Vet Intern Med 2007; 22: 892-896.
5. Bos JM, Ommen SR, Ackerman MJ. Genetics of hypertrophic cardiomyopathy: One, two or more diseases. Curr Opin Cardiol 2007; 22: 193-199.
6. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics. J Cardiovasc Electrophysiol 2007; 19: 1-7.
7. Keren A, Syrris P, McKenna WJ. Hypretrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008; 5: 158-168.
8. Rozen S, Skaletsky HJ. Primer 3 on the WWW for general users and for biologist programmers. In: Krawetz SA, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Human Press; 2000:365-386.
9. Genomics of Cardiovascular Development, Adaptation, and Remodeling. NHLBI Program for Genomic Applications, Harvard Medical School July 2007 to January 2008.
10. Alders M, Jongbloed R, Deelen W, et al. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 2003; 24: 1848-1853.
11. Moolman-Smook JC, De Lange WJ, Bruwer ECD, et al. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events. Am J Hum Genet 1999; 65: 1308-1320.
12. Watkins H, Thierfelder L, Anan R, et al. Independent origin of identical beta cardiac myosin heavy chain mutations in hyerptrophic cardiomyopathy. Am J Hum Genet 1993; 53: 1180-1185.